Scholarly Works - Conferences
Conference
Ann Surg Oncol
·
February 2026
BACKGROUND: Veterans Affairs (VA) patients participate within the largest USA equal-access healthcare system, though still experience cancer mortality disparities by social determinants. The Social Vulnerability Index (SVI)-measuring community poverty, min ...
Full text
Link to item
Cite
Conference
Journal of Clinical Oncology
·
January 20, 2024
724Background: Small bowel adenocarcinoma (SBA) is a rare malignancy with poor prognosis. Data describing the clinical and pathologic characteristics of this disease are sparse, and few studies examine the genetic footprint of SBAs within the continuum of ...
Full text
Cite
Conference
Ann Surg Oncol
·
December 2019
BACKGROUND: Talimogene laherparepvec (T-VEC) is the first injectable oncolytic viral therapy approved for in-transit melanoma metastasis, with a reported overall response rate (ORR) of 25% and complete response rate (CRR) of 10%. To ascertain the role of p ...
Full text
Link to item
Cite